• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型神经纤维瘤病误诊为弱视——病例报告及文献复习

Neurofibromatosis type 2 misdiagnosed as amblyopia-a case report and literature review.

作者信息

Li Qian, Liu Guiqin

机构信息

The Second Clinical Medical College of Jinan University, Shenzhen Eye Hospital, Shenzhen, Guangdong, China.

Shenzhen Eye Hospital, Shenzhen, Guangdong, China.

出版信息

Front Med (Lausanne). 2025 Aug 7;12:1556494. doi: 10.3389/fmed.2025.1556494. eCollection 2025.

DOI:10.3389/fmed.2025.1556494
PMID:40852360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12367767/
Abstract

Neurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannomas, and approximately 40-70% of affected children show ophthalmological involvement. Ophthalmological features may be the first sign of NF2; however, the symptoms associated with ocular lesions are diverse. The onset of NF2 is often obscure, resulting in missed or misdiagnosed cases. Herein, we report a case of NF2 in a child who initially presented with poor eyesight. The child had been treated for amblyopia for 7 years and was referred to the eye oncology department due to a lack of improvement in vision. At birth, a soft mass was noted scattered across the abdominal skin and scalp, which gradually increased in size over time. Ophthalmological examination revealed posterior subcapsular opacity in the right eye and an anterior retinal hamartoma in the left eye. Orbital and cranial magnetic resonance imaging (MRI) indicated that the T1 and T2 signals of multiple structures, including the cone, auditory nerve, trigeminal nerve, left oculomotor nerve, paravertebral, and sublingual region, were more uniform after enhancement. A genetic heterozygous mutation was detected, with no family history of the condition. In addition to this case, we collected and summarized 158 publicly reported cases of NF2 with ophthalmological characteristics. Among these cases, the incidence of visual impairment, strabismus, cataract, retinal anomaly, and retinal hamartoma was high, reaching 64, 38, 25, 23, and 16%, respectively. Through analysis and discussion of the clinical and imaging characteristics of NF2 ocular lesions, we aim to improve ophthalmologists' understanding of this disease, thereby reducing the rate of missed diagnoses.

摘要

2型神经纤维瘤病(NF2)的特征是双侧前庭神经鞘瘤,约40-70%的患病儿童有眼科受累表现。眼科特征可能是NF2的首发症状;然而,与眼部病变相关的症状多种多样。NF2的发病往往隐匿,导致漏诊或误诊。在此,我们报告一例最初表现为视力差的NF2患儿。该患儿因弱视接受了7年治疗,因视力无改善而转诊至眼科肿瘤科。出生时,发现腹部皮肤和头皮散在有柔软肿块,随时间推移肿块逐渐增大。眼科检查发现右眼后囊下混浊,左眼视网膜前错构瘤。眼眶和头颅磁共振成像(MRI)显示,包括视锥、听神经、三叉神经、左动眼神经、椎旁和舌下区域在内的多个结构在增强后T1和T2信号更为均匀。检测到一个基因杂合突变,且无该病家族史。除该病例外,我们收集并总结了158例公开报道的具有眼科特征的NF2病例。在这些病例中,视力损害、斜视、白内障、视网膜异常和视网膜错构瘤的发生率较高,分别达到64%、38%、25%、23%和16%。通过对NF2眼部病变的临床和影像学特征进行分析和讨论,我们旨在提高眼科医生对该病的认识,从而降低漏诊率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/0d76294dc5c4/fmed-12-1556494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/89bfd264dba8/fmed-12-1556494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/f4196f5400dc/fmed-12-1556494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/0d76294dc5c4/fmed-12-1556494-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/89bfd264dba8/fmed-12-1556494-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/f4196f5400dc/fmed-12-1556494-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c0/12367767/0d76294dc5c4/fmed-12-1556494-g003.jpg

相似文献

1
Neurofibromatosis type 2 misdiagnosed as amblyopia-a case report and literature review.2型神经纤维瘤病误诊为弱视——病例报告及文献复习
Front Med (Lausanne). 2025 Aug 7;12:1556494. doi: 10.3389/fmed.2025.1556494. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Surgical interventions for bilateral congenital cataract in children aged two years and under.儿童两岁及以下双侧先天性白内障的手术干预。
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Elbow Fractures Overview肘部骨折概述
6
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.双眼视刺激或常规遮盖治疗法治疗 3-8 岁儿童单眼弱视的比较。
Cochrane Database Syst Rev. 2022 Feb 7;2(2):CD011347. doi: 10.1002/14651858.CD011347.pub3.
7
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
8
Duane Syndrome杜安综合征
9
Interventions for improving adherence to amblyopia treatments in children.改善儿童弱视治疗依从性的干预措施。
Cochrane Database Syst Rev. 2025 Jul 2;7(7):CD015820. doi: 10.1002/14651858.CD015820.pub2.
10
Optic nerve head and fibre layer imaging for diagnosing glaucoma.用于诊断青光眼的视神经乳头和纤维层成像。
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD008803. doi: 10.1002/14651858.CD008803.pub2.

本文引用的文献

1
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.2型神经纤维瘤病相关神经鞘瘤病的基因治疗:最新进展、挑战与未来方向
Oncol Ther. 2024 Jun;12(2):257-276. doi: 10.1007/s40487-024-00279-2. Epub 2024 May 17.
2
Comprehensive review of amblyopia: Types and management.弱视的综合评估:类型与管理。
Indian J Ophthalmol. 2023 Jul;71(7):2677-2686. doi: 10.4103/IJO.IJO_338_23.
3
Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.神经纤维瘤病 2 型相关前庭神经鞘瘤的治疗。
Otolaryngol Clin North Am. 2023 Jun;56(3):533-541. doi: 10.1016/j.otc.2023.02.012. Epub 2023 Mar 22.
4
Neurofibromatosis Type 2: Multiple Meningiomatosis and Vestibular Schwannomas on 68 Ga-DOTATATE PET/CT.神经纤维瘤病 2 型:68Ga-DOTATATE PET/CT 显示多发性脑膜瘤和前庭神经鞘瘤。
Clin Nucl Med. 2022 Nov 1;47(11):e710-e712. doi: 10.1097/RLU.0000000000004355. Epub 2022 Aug 16.
5
Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.儿科神经纤维瘤病 2 型的皮肤科表现:一项横断面描述性多中心研究。
Orphanet J Rare Dis. 2022 Jun 21;17(1):242. doi: 10.1186/s13023-022-02379-6.
6
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.神经纤维瘤病 2 型和雪旺细胞瘤病的更新诊断标准和命名:国际共识建议。
Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9.
7
Surgical outcome and pathological findings in macular epiretinal membrane caused by neurofibromatosis type 2.由神经纤维瘤病 2 型引起的黄斑视网膜前膜的手术结果和病理发现。
Digit J Ophthalmol. 2022 Jan 21;28(1):12-16. doi: 10.5693/djo.02.2021.06.001. eCollection 2022.
8
Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2.神经纤维瘤病 2 型的中央视网膜结构异常。
Ophthalmic Res. 2022;65(1):77-85. doi: 10.1159/000519143. Epub 2021 Oct 21.
9
[Expert consensus on prevention and treatment of amblyopia in children].[儿童弱视防治专家共识]
Zhonghua Yan Ke Za Zhi. 2021 May 11;57(5):336-340. doi: 10.3760/cma.j.cn112142-20210109-00014.
10
New developments in neurofibromatosis type 2 and vestibular schwannoma.2型神经纤维瘤病和前庭神经鞘瘤的新进展。
Neurooncol Adv. 2020 Nov 16;3(1):vdaa153. doi: 10.1093/noajnl/vdaa153. eCollection 2021 Jan-Dec.